Literature DB >> 22180463

Right ventricular function in AL amyloidosis: characteristics and prognostic implication.

Francesco Cappelli1, Maria Cristina Porciani, Franco Bergesio, Stefano Perlini, Paola Attanà, Alberto Moggi Pignone, Francesco Salinaro, Francesco Musca, Luigi Padeletti, Federico Perfetto.   

Abstract

AIM: The importance of right ventricle (RV) dysfunction in AL amyloidosis has been underestimated. This study was designed to comprehensively evaluate RV function and its prognostic role in patients with AL amyloidosis with and without echocardiographic evidence of cardiac involvement. METHOD AND
RESULTS: Fifty-two biopsy-proven AL amyloidosis patients underwent a thorough echocardiographic evaluation. Twenty-seven patients (CA) met the international echocardiographic criteria for cardiac involvement [left ventricular (LV) wall thickness ≥ 12 mm] and 25 patients had no cardiac amyloidosis features (NCA). Patients were compared with a sex- age-matched control group. Patients and controls underwent traditional, tissue Doppler (TDI), speckle-tracking left and RV echocardiographic evaluation. No difference was observed between groups in RV diastolic diameter, whereas CA patients showed increased RV free wall thickness (P< 0.0001). Compared with controls and NCA patients, traditional echocardiography, TDI, and speckle-tracking evaluation detected significantly (P< 0.0001) depressed RV longitudinal systolic function in CA patients. No difference was observed between groups at Doppler diastolic evaluation, whereas at tricuspidal annulus TDI analysis, CA subject showed significantly lower E' and A' values with increased E/E' ratio (P< 0.0001). Over a 19 months median follow-up period, 18 patients died. Cox multivariate analysis showed that N-terminal pro-Brain natriuretic peptide and RV longitudinal strain were the strongest death predictor.
CONCLUSION: Our data show that in patients with AL amyloidosis, RV involvement develops later than LV amyloid deposition but when it occurs, prognosis dramatically worsens. Moreover RV longitudinal strain was the only echocardiographic predictor of prognosis. We suggest that RV function analysis should be performed routinely as a part of echocardiographic evaluation in these patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22180463     DOI: 10.1093/ejechocard/jer289

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  25 in total

1.  Diagnostic and prognostic value of low QRS voltages in cardiac AL amyloidosis.

Authors:  Roberta Mussinelli; Francesco Salinaro; Alessio Alogna; Michele Boldrini; Ambra Raimondi; Francesco Musca; Giovanni Palladini; Giampaolo Merlini; Stefano Perlini
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-01-20       Impact factor: 1.468

2.  Assessment of prognosis in immunoglobulin light chain amyloidosis patients with severe heart failure: a predictive value of right ventricular function.

Authors:  Nobutaka Nagano; Toshiyuki Yano; Yugo Fujita; Hidemichi Kouzu; Masayuki Koyama; Hiroshi Ikeda; Kenji Yasui; Atsuko Muranaka; Ryo Nishikawa; Ryo Takahashi; Naohiro Kishiue; Satoshi Yuda; Tetsuji Miura
Journal:  Heart Vessels       Date:  2019-09-26       Impact factor: 2.037

Review 3.  Echocardiographic evaluation of the right ventricle: a 2014 perspective.

Authors:  Shoshana Gal Portnoy; Lawrence G Rudski
Journal:  Curr Cardiol Rep       Date:  2015       Impact factor: 2.931

4.  ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging.

Authors:  Sharmila Dorbala; Yukio Ando; Sabahat Bokhari; Angela Dispenzieri; Rodney H Falk; Victor A Ferrari; Marianna Fontana; Olivier Gheysens; Julian D Gillmore; Andor W J M Glaudemans; Mazen A Hanna; Bouke P C Hazenberg; Arnt V Kristen; Raymond Y Kwong; Mathew S Maurer; Giampaolo Merlini; Edward J Miller; James C Moon; Venkatesh L Murthy; C Cristina Quarta; Claudio Rapezzi; Frederick L Ruberg; Sanjiv J Shah; Riemer H J A Slart; Hein J Verberne; Jamieson M Bourque
Journal:  J Nucl Cardiol       Date:  2019-12       Impact factor: 5.952

5.  Echocardiography for Evaluation of Oncology Therapy-Related Cardiotoxicity.

Authors:  Chun-Li Wang; Pao-Hsien Chu
Journal:  Acta Cardiol Sin       Date:  2016-09       Impact factor: 2.672

Review 6.  New and Evolving Concepts Regarding the Prognosis and Treatment of Cardiac Amyloidosis.

Authors:  Stefano Perlini; Roberta Mussinelli; Francesco Salinaro
Journal:  Curr Heart Fail Rep       Date:  2016-12

7.  How to image cardiac amyloidosis.

Authors:  Rodney H Falk; Candida C Quarta; Sharmila Dorbala
Journal:  Circ Cardiovasc Imaging       Date:  2014-05       Impact factor: 7.792

8.  Liver dysfunction as predictor of prognosis in patients with amyloidosis: utility of the Model for End-stage Liver disease (MELD) scoring system.

Authors:  Francesco Cappelli; Samuele Baldasseroni; Franco Bergesio; Valentina Spini; Alessia Fabbri; Paola Angelotti; Elisa Grifoni; Paola Attanà; Francesca Tarantini; Niccolò Marchionni; Alberto Moggi Pignone; Federico Perfetto
Journal:  Intern Emerg Med       Date:  2016-08-01       Impact factor: 3.397

9.  Accuracy of 99mTc-Hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis.

Authors:  Francesco Cappelli; Chiara Gallini; Carlo Di Mario; Egidio Natalino Costanzo; Luca Vaggelli; Francesca Tutino; Alfonso Ciaccio; Simone Bartolini; Paola Angelotti; Sabrina Frusconi; Silvia Farsetti; Giuseppe Vergaro; Assuero Giorgetti; Paolo Marzullo; Dario Genovesi; Michele Emdin; Federico Perfetto
Journal:  J Nucl Cardiol       Date:  2017-05-23       Impact factor: 5.952

Review 10.  How to Image Cardiac Amyloidosis: A Practical Approach.

Authors:  Sharmila Dorbala; Sarah Cuddy; Rodney H Falk
Journal:  JACC Cardiovasc Imaging       Date:  2019-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.